| Factor Information | |
|---|---|
| Data ID | 1099 |
| Factor | Stay at PICU, d--Patients < 30 d |
| Description | The characteristics of the neonates < 30 days, as well as the surgery data and the classification of the patients into groups according to the presence or absence of LCOS after CPB. |
| Biomarker | NA |
| Classification | A12 (clinical factor - treatment) |
| Association | |
|---|---|
| Application | prognosis |
| Objective | To assess the predictive value of atrial natriuretic peptide, b-type natriuretic peptide, copeptin, mid-regional pro-adrenomedullin (MR-proADM) and cardiac troponin I (cTn-I) as indicators of low cardiac output syndrome in children with congenital heart disease undergoing cardiopulmonary bypass (CPB). |
| p Value | 0.062 |
| Conclusion | The characteristics of the neonates < 30 days, as well as the surgery data and the classification of the patients into groups according to the presence or absence of LCOS after CPB. |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 500 |
| CHD Type | isolated CHD/non-isolated CHD |
| CHD Subtype | TOF/AVC/CoA/IAA/PA/TGA/VSD, ASD/CAT/HLHS/TAPVC/AR/other |
| Reference | |
|---|---|
| PMID | 28137395 |
| Year | 2017 |
| Title | Cardiac Biomarkers of Low Cardiac Output Syndrome in the Postoperative Period After Congenital Heart Disease Surgery in Children. |
| Sample | ||
|---|---|---|
| Population | children | |
| Source | blood | |
| Region | Co´rdoba,Spain | |
| Method | a prospective observational pilot study | |
| Race | Europe | |
| Disease History | N/A | |
| Treatment History | corrective surgery | |
| Group | group 1: with LCOS(Treatment) | group 2: without LCOS(Control) |
| Number | 8 | 11 |
| Age | 8.5 ± 4 years | 9.5 ± 4 years |
| Gender (Male: Female) | 4:4 | 9:2 |
| Marker Level | 22.5 (12-39) | 11 (9-16) |
